Growth differentiation factor-15 encodes a novel microRNA 3189 that functions as a potent regulator of cell death

M F Jones1, X Ling Li1, M Subramanian1

  • 1Regulatory RNAs and Cancer Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Insights

We discovered miR-3189, a novel primate-specific microRNA (miRNA) that acts as a tumor suppressor. It induces apoptosis through both p53-dependent and independent pathways, offering therapeutic potential for various cancers.

Area of Science:

  • * Molecular Biology
  • * Genetics
  • * Oncology

Background:

  • * MicroRNAs (miRNAs) are small non-coding RNAs regulating gene expression.
  • * A significant portion of miRNAs are primate-specific, yet their functions are largely unknown.
  • * The tumor suppressor protein p53 plays a critical role in cellular responses to DNA damage and cancer development.

Purpose of the Study:

  • * To identify and characterize novel primate-specific miRNAs.
  • * To investigate the function and regulatory mechanisms of miR-3189.
  • * To explore the therapeutic potential of miR-3189 in cancer treatment.

Main Methods:

  • * Identification of novel miRNAs using bioinformatics and experimental approaches.
  • * Luciferase reporter assays to confirm direct miRNA-target interactions.
  • * Cell proliferation, apoptosis, and DNA damage assays.
  • * In vivo tumorigenicity studies in mouse models.
  • * Analysis of p53-dependent and independent gene regulation.

Main Results:

  • * miR-3189 was identified as a novel, p53-regulated, primate-specific miRNA.
  • * Endogenous miR-3189 exhibits tumor suppressor activity by inhibiting proliferation and promoting apoptosis.
  • * miR-3189 directly targets genes involved in cell cycle control and survival.
  • * miR-3189 upregulates p53 levels by inhibiting p53 inhibitors, suggesting auto-regulation.
  • * miR-3189 induces apoptosis and inhibits tumorigenicity in a p53-independent manner.

Conclusions:

  • * miR-3189 is a primate-specific miRNA with significant tumor suppressor functions.
  • * Its effects are mediated through both p53-dependent and p53-independent pathways.
  • * miR-3189 holds promise as a therapeutic agent for inducing apoptosis, even in p53-deficient tumors.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.9K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.4K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.4K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
11.1K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
4.0K